Medicare Enrolled

Dr. Veena Nayak, M.D.

Rheumatology · Olympia Fields, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
20060 GOVERNORS DR, Olympia Fields, IL 60461
7082832600
In practice since 2005 (20 years)
NPI: 1376539106 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nayak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nayak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nayak

Dr. Veena Nayak is a rheumatology specialist in Olympia Fields, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nayak performed 131,981 Medicare services across 466 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nayak received a total of $23,252 from 47 pharmaceutical and/or device companies across 860 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nayak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 5% volume in IL $23,252 industry payments

Medicare Practice Summary

Medicare Utilization ↗
131,981
Medicare services
Top 5% in IL for rheumatology
466
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,599 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
102,401 $4 $15
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
14,325 $34 $75
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
13,500 $10 $65
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
722 $95 $224
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
513 $59 $250
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
298 $107 $300
Physical therapy exercise, per 15 min
A therapy session using exercises to improve strength, endurance, range of motion, and flexibility. Each 15-minute unit is billed separately.
144 $20 $105
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
50 $135 $364
Evaluation for physical therapy, typically 30 minutes 17 $73 $220
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
11 $66 $155
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
21.3% high complexity
78.0% medium
0.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$23,252
Total received (2018-2024)
Avg $3,322/year across 7 years
Top 12% in IL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
860
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,957 (81.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,163 (17.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$132 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,499
2023
$2,598
2022
$2,973
2021
$2,072
2020
$1,755
2019
$5,563
2018
$3,792

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$2,756
ABBVIE INC.
$496
Amgen Inc.
$381
PFIZER INC.
$188
E.R. Squibb & Sons, L.L.C.
$95
Alexion Pharmaceuticals, Inc.
$88
UCB, Inc.
$86
Novartis Pharmaceuticals Corporation
$69
GlaxoSmithKline, LLC.
$60
Organon Llc
$52
AstraZeneca Pharmaceuticals LP
$50
Genentech USA, Inc.
$40
GENZYME CORPORATION
$27
Mallinckrodt Hospital Products Inc.
$27
ANI Pharmaceuticals, Inc.
$25
Kyowa Kirin, Inc.
$23
Ultragenyx Pharmaceutical Inc.
$20
Sandoz Inc.
$15
Top 3 companies account for 80.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$5,492
Amgen Inc.
$2,923
UCB, Inc.
$1,646
ABBVIE INC.
$1,312
PFIZER INC.
$1,245
E.R. Squibb & Sons, L.L.C.
$1,190
AbbVie, Inc.
$917
Lilly USA, LLC
$848
Boehringer Ingelheim Pharmaceuticals, Inc.
$667
Novartis Pharmaceuticals Corporation
$640
Antares Pharma, Inc.
$613
AbbVie Inc.
$569
AstraZeneca Pharmaceuticals LP
$555
Janssen Scientific Affairs, LLC
$490
Celgene Corporation
$485
GlaxoSmithKline, LLC.
$477
Horizon Therapeutics plc
$464
Genentech USA, Inc.
$438
Mallinckrodt Hospital Products Inc.
$331
GENZYME CORPORATION
$257
Mallinckrodt LLC
$204
Mallinckrodt Enterprises LLC
$182
Alexion Pharmaceuticals, Inc.
$143
Fresenius Kabi USA, LLC
$100
MEDAC PHARMA, INC.
$95
Aurinia Pharma U.S., Inc.
$88
Ultragenyx Pharmaceutical Inc.
$88
Flexion Therapeutics, Inc.
$79
TerSera Therapeutics LLC
$66
Actelion Pharmaceuticals US, Inc.
$62
Exeltis, USA Inc.
$57
SANOFI-AVENTIS U.S. LLC
$53
Merck Sharp & Dohme Corporation
$53
Organon Llc
$52
ANI Pharmaceuticals, Inc.
$50
Ironwood Pharmaceuticals, Inc
$44
Sandoz Inc.
$38
Sobi, Inc
$33
Radius Health, Inc.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$30
Organon LLC
$26
SI-BONE, Inc.
$24
Kyowa Kirin, Inc.
$23
Celltrion USA Inc.
$19
SOBI, INC
$19
Assertio Therapeutics, Inc.
$18
Horizon Pharma plc
$13
Top 3 companies account for 43.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · DUZALLO · EVENITY · EVUSHELD · Enbrel · FORTEO · Gralise · HADLIMA · HUMIRA · HYRIMOZ · Humira · IDACIO · ILARIS · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · OFEV · OLUMIANT · OPSUMIT · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ · XYOSTED · YUFLYMA · Zilretta · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Olympia Fields?
Compare rheumatologists in the Olympia Fields area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
88
Per 100K population
1.7
County median income
$81,797
Nearest hospital
FRANCISCAN HEALTH OLYMPIA & CHICAGO HEIGHTS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nayak is a mixed practice specialist, with above-average Medicare volume (top 5% in IL), with low-engagement industry engagement in the top 12% of IL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nayak experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Nayak performed 102,401 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nayak receive payments from pharmaceutical companies?
Yes. Dr. Nayak received a total of $23,252 from 47 companies across 860 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nayak's costs compare to other rheumatologists in Olympia Fields?
Dr. Nayak's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nayak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →